• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    3.52 Down 0.07(1.95%) Feb 5, 4:00PM EST
    Prev Close:3.59
    Open:3.60
    Bid:3.50 x 2100
    Ask:6.75 x 600
    1y Target Est:7.30
    Beta:2.90119
    Earnings Date:Mar 7 - Mar 11 (Est.)
    Day's Range:3.50 - 3.74
    52wk Range:2.59 - 9.32
    Volume:175,668
    Avg Vol (3m):522,910
    Market Cap:156.45M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXDown 1.95%156.45M
    BAXDown 2.09%20.51B
    CFN 0.00%12.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.42
    Quarterly EPS Est (Dec-15) :-0.10
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback